Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bethanechol and Early Bladder Training for Bladder Dysfunction Prevention after Radical Hysterectomy
NCT02910596Phase 4
Key facts
- Status
- Completed
- Start
- Oct 2016
- Primary completion
- Mar 2017
- Countries
- 1
- Sponsor
- Ministry of Public Health
- Modality
- Small Molecules
- Drugs
- bethanechol
- Conditions
- Bladder dysfunction
01
Overview
Phase 4, randomised, open-label trial of bethanechol in Bladder dysfunction, sponsored by Ministry of Public Health. Primary endpoint: Duration of retrained urethral catheterization at 5 days. Started Oct 2016; status: completed.
02
Design
- Study design
- RandomizedOpen-label
03
Who it enrols
Women aged 20-65 with cervical cancer stage IB-IIA undergoing standard type III radical hysterectomy, excluding those with neurogenic bladder or bethanechol allergy.
04
Endpoints
Primary
Duration of retrained urethral catheterization
Beyond the preview
Go deeper on NCT02910596.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02910596.